FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133633037> ?p ?o ?g. }

• W3133633037 abstract "It remains undefined whether a subset of CD4+ T cells can function as fast-acting cells to control Mycobacterium tuberculosis (Mtb) infection. Here we show that the primary CD4+CD161+ T-cell subset, not CD4+CD161-, in unexposed healthy humans fast acted as unconventional T cells capable of inhibiting intracellular Mtb and BCG growth upon exposure to infected autologous and allogeneic macrophages or lung epithelial A549 cells. Such inhibition coincided with the ability of primary CD4+CD161+ T cells to rapidly express/secrete anti-TB cytokines including IFN-γ, TNF-α, IL-17, and perforin upon exposure to Mtb. Mechanistically, blockades of CD161 pathway, perforin or IFN-γ by blocking mAbs abrogated the ability of CD4+CD161+ T cells to inhibit intracellular mycobacterial growth. Pre-treatment of infected macrophages with inhibitors of autophagy also blocked the CD4+CD161+ T cell-mediated growth inhibition of mycobacteria. Furthermore, adoptive transfer of human CD4+CD161+ T cells conferred protective immunity against mycobacterial infection in SCID mice. Surprisingly, CD4+CD161+ T cells in TB patients exhibited a loss or reduction of their capabilities to produce perforin/IFN-γ and to inhibit intracellular growth of mycobacteria in infected macrophages. These immune dysfunctions were consistent with PD1/Tim3 up-regulation on CD4+CD161+ T cells in active tuberculosis patients, and the blockade of PD1/Tim3 on this subset cells enhanced the inhibition of intracellular mycobacteria survival. Thus, these findings suggest that a fast-acting primary CD4+CD161+T-cell subset in unexposed humans employs the CD161 pathway, perforin, and IFN-γ/autophagy to inhibit the growth of intracellular mycobacteria, thereby distinguishing them from the slow adaptive responses of conventional CD4+ T cells. The presence of fast-acting CD4+CD161+ T-cell that inhibit mycobacterial growth in unexposed humans but not TB patients also implicates the role of these cells in protective immunity against initial Mtb infection." @default.
• W3133633037 created "2021-03-15" @default.
• W3133633037 creator A5004363711 @default.
• W3133633037 creator A5011609847 @default.
• W3133633037 creator A5026487071 @default.
• W3133633037 creator A5035917075 @default.
• W3133633037 creator A5037930685 @default.
• W3133633037 creator A5040615889 @default.
• W3133633037 creator A5052850535 @default.
• W3133633037 creator A5066248375 @default.
• W3133633037 creator A5066424998 @default.
• W3133633037 creator A5078243832 @default.
• W3133633037 creator A5079126153 @default.
• W3133633037 creator A5087748027 @default.
• W3133633037 date "2021-02-26" @default.
• W3133633037 modified "2023-10-03" @default.
• W3133633037 title "A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy" @default.
• W3133633037 cites W1528084970 @default.
• W3133633037 cites W1530296977 @default.
• W3133633037 cites W1562342535 @default.
• W3133633037 cites W1904297401 @default.
• W3133633037 cites W1920701053 @default.
• W3133633037 cites W1981102729 @default.
• W3133633037 cites W1985447596 @default.
• W3133633037 cites W2011770661 @default.
• W3133633037 cites W2016061623 @default.
• W3133633037 cites W2017037510 @default.
• W3133633037 cites W2022561016 @default.
• W3133633037 cites W2042814843 @default.
• W3133633037 cites W2047944199 @default.
• W3133633037 cites W2051752235 @default.
• W3133633037 cites W2055819944 @default.
• W3133633037 cites W2060963592 @default.
• W3133633037 cites W2061899137 @default.
• W3133633037 cites W2075477269 @default.
• W3133633037 cites W2083325443 @default.
• W3133633037 cites W2087920955 @default.
• W3133633037 cites W2091287374 @default.
• W3133633037 cites W2100219680 @default.
• W3133633037 cites W2100990607 @default.
• W3133633037 cites W2103558694 @default.
• W3133633037 cites W2115128014 @default.
• W3133633037 cites W2116654815 @default.
• W3133633037 cites W2126488454 @default.
• W3133633037 cites W2132999784 @default.
• W3133633037 cites W2135437388 @default.
• W3133633037 cites W2147172932 @default.
• W3133633037 cites W2158372391 @default.
• W3133633037 cites W2164309428 @default.
• W3133633037 cites W2195750355 @default.
• W3133633037 cites W2545972777 @default.
• W3133633037 cites W2589191322 @default.
• W3133633037 cites W2616106896 @default.
• W3133633037 cites W2753051611 @default.
• W3133633037 cites W2789124927 @default.
• W3133633037 cites W2890334235 @default.
• W3133633037 cites W2903583849 @default.
• W3133633037 cites W2910312028 @default.
• W3133633037 cites W2941217482 @default.
• W3133633037 cites W3091990702 @default.
• W3133633037 cites W4236657450 @default.
• W3133633037 cites W4253747742 @default.
• W3133633037 doi "https://doi.org/10.3389/fimmu.2021.599641" @default.
• W3133633037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7959736" @default.
• W3133633037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33732233" @default.
• W3133633037 hasPublicationYear "2021" @default.
• W3133633037 type Work @default.
• W3133633037 sameAs 3133633037 @default.
• W3133633037 citedByCount "8" @default.
• W3133633037 countsByYear W31336330372021 @default.
• W3133633037 countsByYear W31336330372022 @default.
• W3133633037 countsByYear W31336330372023 @default.
• W3133633037 crossrefType "journal-article" @default.
• W3133633037 hasAuthorship W3133633037A5004363711 @default.
• W3133633037 hasAuthorship W3133633037A5011609847 @default.
• W3133633037 hasAuthorship W3133633037A5026487071 @default.
• W3133633037 hasAuthorship W3133633037A5035917075 @default.
• W3133633037 hasAuthorship W3133633037A5037930685 @default.
• W3133633037 hasAuthorship W3133633037A5040615889 @default.
• W3133633037 hasAuthorship W3133633037A5052850535 @default.
• W3133633037 hasAuthorship W3133633037A5066248375 @default.
• W3133633037 hasAuthorship W3133633037A5066424998 @default.
• W3133633037 hasAuthorship W3133633037A5078243832 @default.
• W3133633037 hasAuthorship W3133633037A5079126153 @default.
• W3133633037 hasAuthorship W3133633037A5087748027 @default.
• W3133633037 hasBestOaLocation W31336330371 @default.
• W3133633037 hasConcept C153726182 @default.
• W3133633037 hasConcept C154317977 @default.
• W3133633037 hasConcept C167672396 @default.
• W3133633037 hasConcept C190283241 @default.
• W3133633037 hasConcept C202751555 @default.
• W3133633037 hasConcept C203014093 @default.
• W3133633037 hasConcept C203522944 @default.
• W3133633037 hasConcept C2776062744 @default.
• W3133633037 hasConcept C2776090121 @default.
• W3133633037 hasConcept C55493867 @default.
• W3133633037 hasConcept C79879829 @default.
• W3133633037 hasConcept C86803240 @default.
• W3133633037 hasConcept C8891405 @default.
• W3133633037 hasConcept C95444343 @default.

• next